ID: ALA5269374

Max Phase: Preclinical

Molecular Formula: C18H16O

Molecular Weight: 248.32

Associated Items:

Representations

Canonical SMILES:  Cc1ccc2c(c1C)C(=O)/C(=C/c1ccccc1)C2

Standard InChI:  InChI=1S/C18H16O/c1-12-8-9-15-11-16(18(19)17(15)13(12)2)10-14-6-4-3-5-7-14/h3-10H,11H2,1-2H3/b16-10+

Standard InChI Key:  GUUFGKDRGZJQMO-MHWRWJLKSA-N

Associated Targets(Human)

Serine/threonine-protein kinase AKT 245 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 248.32Molecular Weight (Monoisotopic): 248.1201AlogP: 4.13#Rotatable Bonds: 1
Polar Surface Area: 17.07Molecular Species: HBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.92CX LogD: 4.92
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.69Np Likeness Score: 0.17

References

1. Lazinski LM, Royal G, Robin M, Maresca M, Haudecoeur R..  (2022)  Bioactive Aurones, Indanones, and Other Hemiindigoid Scaffolds: Medicinal Chemistry and Photopharmacology Perspectives.,  65  (19.0): [PMID:36126323] [10.1021/acs.jmedchem.2c01150]

Source